India Pesticides Ltd Q4 FY25 Results

Despite headwinds in international markets, India Pesticides Limited demonstrated resilience and delivered a strong performance across operational, strategic, and financial parameters. This performance underscores our focus on long-term value creation through manufacturing scale-up, targeted R&D initiatives, and an emphasis on a differentiated product portfolio. During the year, the Company achieved its Revenue of %843 crore, reflecting a growth of 21.3% YoY. This growth was primarily volume-led, supported by sustained demand in the domestic market and a strategic product mix catering to both domestic and international customers. One of the key milestones was the successful commissioning of the expanded intermediate PEDA facility. Looking ahead, the Company is on track to expand capacity to 8,500 MT per annum by Q2 FY26, which aligns with our long-term growth plans and supports the Government of India’s Aatma Nirbhar Bharat initiative. Our R&D efforts have gathered momentum, resulting in the development of several new molecules. India Pesticides Limited is increasingly recognized as a trusted partner by both domestic and global players, with all major Indian companies sourcing one or more key molecules from us. Our expansion plans remain firmly on track. During FY2025-26, we intend to undertake capital expenditure of %52 crore at our existing manufacturing facilities and %64 crore at our wholly owned subsidiary, Shalvis Specialities Limited. As we look ahead in FY2025-26, the Company remains committed to executing its strategic priorities and accelerating its growth trajectory. With a balanced product portfolio, strong domestic positioning, expanding manufacturing capacity, and advancing R&D capabilities, we are well placed to capitalise on emerging opportunities and navigate the evolving dynamics of the global agrochemical landscape. We are optimistic about the long-term prospects of our Company and remain committed to delivering sustainable value to all our stakeholders.